{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:44:34Z","timestamp":1770187474463,"version":"3.49.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>\n                    A 72-year-old man underwent\n                    <jats:sup>18<\/jats:sup>\n                    F-DCFPyL PSMA PET\/CT imaging for the localization of biochemical recurrence (BCR) of prostate cancer. The scan revealed no definite findings, with only a vague uptake of uncertain significance in the bladder neck region. An additional PET\/CT scan using a\n                    <jats:sup>64<\/jats:sup>\n                    Cu-labeled trimeric PSMA ligand demonstrated astonishing distinct uptake in the former prostate bed, unequivocally confirming the presence of a small local recurrence and allowing for targeted local therapy. This intriguing case highlights the potential of PET\/CT using\n                    <jats:sup>64<\/jats:sup>\n                    Cu-labeled trimeric PSMA ligands, especially when conventional PSMA PET\/CT scans yield ambiguous results.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006010","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T16:06:30Z","timestamp":1749139590000},"page":"e195-e196","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Novel 64Cu-labeled Trimeric PSMA Ligand Unequivocally Identifies Local Recurrence of Prostate Cancer Ambiguously Imaged by 18F-DCFPyL PSMA PET\/CT"],"prefix":"10.1097","volume":"51","author":[{"given":"Mark","family":"Bartholom\u00e4","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Rosar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Burgard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Maus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz-Valentin","family":"Schreck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-3375","authenticated-orcid":false,"given":"Samer","family":"Ezziddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"R1-20260203","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/14737140.2022.2081155","article-title":"Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancer","volume":"22","author":"Voter","year":"2022","journal-title":"Expert Rev Anticancer Ther"},{"key":"R2-20260203","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2967\/jnumed.119.234799","article-title":"18F-DCFPyL PET\/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy","volume":"61","author":"Mena","year":"2020","journal-title":"J Nucl Med"},{"key":"R3-20260203","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2967\/jnumed.121.262347","article-title":"Predictors of 18F-DCFPyL PET\/CT positivity in patients with biochemical recurrence of prostate cancer after local therapy","volume":"63","author":"Mena","year":"2022","journal-title":"J Nucl Med"},{"key":"R4-20260203","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s00259-021-05189-3","article-title":"Performance of [68Ga]Ga-PSMA-11 PET\/CT in patients with recurrent prostate cancer after prostatectomy\u2014a multi-centre evaluation of 2533 patients","volume":"48","author":"Afshar-Oromieh","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20260203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cpet.2009.04.013","article-title":"Copper-64 radiopharmaceuticals for oncologic imaging","volume":"4","author":"Holland","year":"2009","journal-title":"PET Clin"},{"key":"R6-20260203","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1007\/s00259-022-05925-3","article-title":"[89Zr]Zr-PSMA-617 PET\/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates","volume":"49","author":"Rosar","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-20260203","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40644-024-00778-5","article-title":"Outstanding increase in tumor-to-background ratio over time allows tumor localization by [89Zr]Zr-PSMA-617 PET\/CT in early biochemical recurrence of prostate cancer","volume":"24","author":"Burgard","year":"2024","journal-title":"Cancer Imaging"},{"key":"R8-20260203","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s41181-024-00314-7","article-title":"Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform","volume":"9","author":"Martin","year":"2024","journal-title":"EJNMMI Radiopharm Chem"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:00:50Z","timestamp":1770141650000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006010","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"2025-03-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}